Drugs / SB-715992
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00136578 | Oct 2004 → Oct 2006 | cancer | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00169520 | Jun 2004 → ? | — | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB-715992 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00136578 ↗ |
| Route | Intravenous | “1-hour intravenous infusion” NCT00136578 ↗ |